UA88769U - Method for preventing and treating benign breast dysplasia in patients with early miscarriage - Google Patents
Method for preventing and treating benign breast dysplasia in patients with early miscarriageInfo
- Publication number
- UA88769U UA88769U UAU201313731U UAU201313731U UA88769U UA 88769 U UA88769 U UA 88769U UA U201313731 U UAU201313731 U UA U201313731U UA U201313731 U UAU201313731 U UA U201313731U UA 88769 U UA88769 U UA 88769U
- Authority
- UA
- Ukraine
- Prior art keywords
- patients
- preventing
- benign breast
- treating benign
- breast dysplasia
- Prior art date
Links
- 206010000234 Abortion spontaneous Diseases 0.000 title abstract 2
- 206010006237 Breast dysplasia Diseases 0.000 title abstract 2
- 208000000571 Fibrocystic breast disease Diseases 0.000 title abstract 2
- 238000000034 method Methods 0.000 title abstract 2
- 208000015994 miscarriage Diseases 0.000 title abstract 2
- 208000000995 spontaneous abortion Diseases 0.000 title abstract 2
- 102000004190 Enzymes Human genes 0.000 abstract 1
- 108090000790 Enzymes Proteins 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 238000011287 therapeutic dose Methods 0.000 abstract 1
- 238000002560 therapeutic procedure Methods 0.000 abstract 1
Landscapes
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
The method for preventing and treating benign breast dysplasia in the patients with early miscarriage comprises the background therapy with the use of Serrata as complex enzyme drug and Tazalok as phytomammoprotector at the average therapeutic doses.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| UAU201313731U UA88769U (en) | 2013-11-26 | 2013-11-26 | Method for preventing and treating benign breast dysplasia in patients with early miscarriage |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| UAU201313731U UA88769U (en) | 2013-11-26 | 2013-11-26 | Method for preventing and treating benign breast dysplasia in patients with early miscarriage |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| UA88769U true UA88769U (en) | 2014-03-25 |
Family
ID=56267884
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| UAU201313731U UA88769U (en) | 2013-11-26 | 2013-11-26 | Method for preventing and treating benign breast dysplasia in patients with early miscarriage |
Country Status (1)
| Country | Link |
|---|---|
| UA (1) | UA88769U (en) |
-
2013
- 2013-11-26 UA UAU201313731U patent/UA88769U/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2017014338A (en) | Targeted selection of patients for treatment with cortistatin derivatives. | |
| MX2020004023A (en) | Use of a pcsk9 inhibitor to treat hyperlipidemia. | |
| MX377729B (en) | Methods of treating melanoma | |
| MX380273B (en) | ANTIBODY DRUG CONJUGATES (ADCS) WITH KSP INHIBITORS. | |
| CL2016000354A1 (en) | Modulation of tumor immunity | |
| MX2016002645A (en) | Combination therapy for the treatment of glioblastoma. | |
| NZ716473A (en) | Diagnosis and therapy of cancer involving cancer stem cells | |
| SG10201808102WA (en) | Bicyclic heterocycle compounds and their uses in therapy | |
| SG10201902074UA (en) | Heterocyclic compounds and uses thereof | |
| PH12014502048B1 (en) | Treatment of cancer with tor kinase inhibitors | |
| MX2016010504A (en) | Methods for treating patients with hypercholesterolemia that is not adequately controlled by moderate-dose statin therapy. | |
| CL2015002807A1 (en) | Combination therapy | |
| PH12015500246A1 (en) | Pharmaceutical combinations comprising a b-raf inhibitor, an egfr inhibitor and optionally a pi3k-alpha inhibitor | |
| ZA201700196B (en) | Methods for treating high cardiovascular risk patients with hypercholesterolemia | |
| MX2015011899A (en) | Methods of treating cancer and preventing cancer drug resistance. | |
| PH12014502029A1 (en) | Treatment of cancer with tor kinase inhibitors | |
| PH12014502046B1 (en) | Treatment of cancer with tor kinase inhibitors | |
| MX2015010791A (en) | Methods of treating cancer and preventing drug resistance. | |
| MX373231B (en) | ANTICANCER AGENT. | |
| CA2908742C (en) | Combination therapy comprising a tor kinase inhibitor and a cytidine analog for treating cancer | |
| MX360189B (en) | Combination therapy for the treatment of glioblastoma. | |
| EA201591987A1 (en) | TREATMENT OF MALIGNANT TUMOR DIHYDROPYRAZINOPIRASINS | |
| IL245738A0 (en) | Oxindole derivatives, preparation thereof and therapeutic use in the treatment of ampk-related diseases | |
| EP3549582A3 (en) | Novel capsazepine analogs for the treatment of cancer and other proliferative diseases | |
| EP2969008A4 (en) | Medicament for treatment of cancer, cardiovascular diseases and inflammation |